Bioequivalence and Bioavailability Forum • Trifluoperazine

Trifluoperazine [Design Issues]

posted by drgunasakaran1 – 2013-02-17 09:53 (4882 d 07:21 ago) – Posting: # 10047
Views: 8,296

Dear Mr Ken,

❝ Nevertheless, we could highly find sufficient information on this drug.

There are only limited information available regarding the variability of Trifluoperazine. As per the literature, Peak plasma concentrations varied widely (range 0.53-3.09 ng/ml) and were reached 2.8 +/- 0.5 h following ingestion of the Trifluoperazine tablet. The area under the plasma concentration-time curve differed widely between subjects (range: 5.9-17.6 ng ml-1 h) suggesting large individual differences in the extent of presystemic Trifluoperazine elimination.

Reference

—
Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

Trifluoperazine Ken Peh 2013-02-16 16:26
- Trifluoperazinedrgunasakaran1 2013-02-17 08:53
  - Trifluoperazine Ken Peh 2013-02-18 07:28
    - Pilot or Two-Stage Helmut 2013-02-18 13:53
      - Pilot or Two-Stage Ken Peh 2013-02-18 18:19
        
        Pilot or Two-Stage Helmut 2013-02-19 13:37
        
        Pilot or Two-Stage Ken Peh 2013-02-20 03:34
        
        Post hoc power & other things… Helmut 2013-02-20 20:11
        
        Post hoc power & other things… Ken Peh 2013-02-22 08:17
        
        Post hoc power & other things… Helmut 2013-02-22 14:15
        
        Post hoc power & other things… Ken Peh 2013-02-24 09:08
        
        estimation ≠ calculation Helmut 2013-02-24 17:09